Both in Pharmaceuticals
Arcutis Biotherapeutics vs Edgewise Therapeutics
Over the past year ARQT returned +41.8% and EWTX returned +116.6%; their daily moves had a correlation of 0.28.
ARQT +41.8% EWTX +116.6%Growth of $1, one year, split-adjusted
| Metric | ARQT | EWTX |
|---|---|---|
| Price | $34.05 | $37.53 |
| Market cap | $4.28B | $4.08B |
| Today | +6.41% | −0.40% |
| 1 month | +42.3% | −6.2% |
| 6 months | +40.9% | +1.5% |
| Year to date | +17.3% | +51.2% |
| 1 year | +37.5% | +108.8% |
| Revenue growth (YoY) | +59.3% | — |
| Gross margin | 91.6% | — |
| Net margin | 11.6% | — |
| P/E (TTM) | 150.1× | — |
| Price / sales | 9.2× | — |
| Net cash | $129.7M | $460.7M |
| Dividend yield | — | — |
| Volatility (60d) | 54.8% | 41.4% |
| Short % of float | 18.0% | 16.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).